DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
83.09
+0.43 (0.52%)
Aug 6, 2026, 2:29 PM EDT - Market open
DexCom Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 999.7 | 836.3 | 576.2 | 541.5 | 341.2 | 216.9 |
Depreciation & Amortization | 264.1 | 251.8 | 217.7 | 186 | 155.9 | 102 |
Stock-Based Compensation | 162.4 | 159.6 | 170.4 | 150.8 | 126.5 | 113.4 |
Other Adjustments | 193.2 | 89.6 | -83.6 | -133 | 19.2 | 142.2 |
Change in Receivables | 84.1 | -201.9 | -35 | -260.1 | -199.9 | -75.5 |
Changes in Inventories | -153 | -63.7 | 12.4 | -252.6 | 49.3 | -112.2 |
Changes in Accounts Payable | 245.6 | 347 | 211.7 | 466.5 | 295.1 | 58 |
Changes in Accrued Expenses | 8 | 55.4 | -60 | 37.2 | 8.5 | 10.4 |
Changes in Unearned Revenue | -3.5 | -11.5 | -8 | -2.6 | 11.1 | 8.7 |
Changes in Other Operating Activities | 16.2 | -21.9 | -12.3 | 14.8 | -137.4 | -21.4 |
Operating Cash Flow | 1,749 | 1,441 | 989.5 | 748.5 | 669.5 | 442.5 |
Operating Cash Flow Growth | 77.05% | 45.60% | 32.20% | 11.80% | 51.30% | -6.96% |
Capital Expenditures | -343.7 | -363.5 | -358.8 | -236.6 | -364.8 | -389.2 |
Purchases of Investments | -955.3 | -1,266 | -2,658 | -3,220 | -2,281 | -2,473 |
Proceeds from Sale of Investments | 1,870 | 2,165 | 2,824 | 2,947 | 2,128 | 2,666 |
Cash Acquisitions | - | - | - | - | -3.9 | -30.2 |
Other Investing Activities | 1.1 | 0.6 | -15.5 | 1.9 | 0.2 | 10.1 |
Investing Cash Flow | 530.7 | 536 | -207.5 | -507.2 | -521.5 | -216.1 |
Long-Term Debt Issued | - | - | - | 1,231 | - | - |
Long-Term Debt Repaid | - | -1,208 | - | -787.3 | - | - |
Net Long-Term Debt Issued (Repaid) | - | -1,208 | - | 443.3 | - | - |
Issuance of Common Stock | 26.6 | 28.1 | 28.2 | 26.6 | 22.5 | 20.3 |
Repurchase of Common Stock | -500 | -500 | -750 | -688.7 | -557.7 | - |
Net Common Stock Issued (Repurchased) | -473.4 | -471.9 | -721.8 | -662.1 | -535.2 | 20.3 |
Other Financing Activities | -45 | -7 | -13 | -99.8 | -17.3 | -9.9 |
Financing Cash Flow | -2,330 | -1,686 | -734.8 | -318.6 | -552.5 | 10.4 |
Foreign Exchange Rate Adjustments | -5 | 21.5 | -7.4 | 1.5 | -5.8 | -1.4 |
Net Cash Flow | -55.1 | 311.8 | 39.8 | -75.8 | -410.3 | 235.4 |
Free Cash Flow | 1,405 | 1,077 | 630.7 | 511.9 | 304.7 | 53.3 |
Free Cash Flow Growth | 146.15% | 70.79% | 23.21% | 68.00% | 471.67% | -80.73% |
FCF Margin | 28.27% | 23.11% | 15.64% | 14.13% | 10.47% | 2.18% |
Free Cash Flow Per Share | 3.53 | 2.66 | 1.53 | 1.20 | 0.71 | 0.12 |
Levered Free Cash Flow | 1,033 | -177.6 | 578.9 | 1,198 | 358.9 | -126.8 |
Unlevered Free Cash Flow | 923.35 | 894.2 | 490.32 | 668.29 | 359.25 | -119.2 |